"Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program." by Roxanne Payne

Selected Works of Walter J. Urba, MD, PhD

Article

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program.

Journal for ImmunoTherapy of Cancer (2014)

Roxanne Payne, Providence Portland Medical Center
Lyn Glenn, Providence Portland Medical Center
Helena Hoen
Beverley Richards
John W Smith, Loyola University Chicago
Robert Lufkin
Todd S Crocenzi, Providence Health & Services
Walter J Urba
Brendan D Curti, Providence Portland Medical Center

Link

Disciplines

Medicine and Health Sciences and
Surgery

Publication Date

January 1, 2014

DOI

10.1186/2051-1426-2-13

Citation Information

Roxanne Payne, Lyn Glenn, Helena Hoen, Beverley Richards, et al.. "Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program." Journal for ImmunoTherapy of Cancer Vol. 2 Iss. 1 (2014) p. 13 - 13
Available at: http://works.bepress.com/walter-urba/131/